Glucagon-secretion inhibition using somatostatin: An old hormone for the treatment of diabetes-associated pancreatectomy.
Assistance publique-Hôpitaux de Paris, Lariboisière Hospital, Department of Diabetes and Endocrinology, DHU FIRE, 75010 Paris, France; University Paris-6, Cordeliers Research Centre, Inserm UMRS 1138, 75006 Paris, France.
J-P
JP
Riveline
University Paris-Diderot Paris-7, Saint-Louis Hospital, Department of Biochemistry, 75010 Paris, France.
P
P
Boudou
University Paris-6, Cordeliers Research Centre, Inserm UMRS 1138, 75006 Paris, France.
B
B
Blondeau
Assistance publique-Hôpitaux de Paris, Lariboisière Hospital, Department of Diabetes and Endocrinology, DHU FIRE, 75010 Paris, France; University Paris-6, Cordeliers Research Centre, Inserm UMRS 1138, 75006 Paris, France. Electronic address: jean-francois.gautier@aphp.fr.
J-F
JF
Gautier
D000328:Adult; D000368:Aged; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D005934:Glucagon / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010180:Pancreatectomy / Q000009:adverse effects*; D013004:Somatostatin / Q000627:therapeutic use*
D013004:Somatostatin; D005934:Glucagon